Progress in cardiovascular bioprinting

Faisal Quadri, Soja Saghar Soman, Sanjairaj Vijayavenkataraman

Research output: Contribution to journalReview articlepeer-review


Cardiovascular disease has been the leading cause of death globally for the past 15 years. Following a major cardiac disease episode, the ideal treatment would be the replacement of the damaged tissue, due to the limited regenerative capacity of cardiac tissues. However, we suffer from a chronic organ donor shortage which causes approximately 20 people to die each day waiting to receive an organ. Bioprinting of tissues and organs can potentially alleviate this burden by fabricating low cost tissue and organ replacements for cardiac patients. Clinical adoption of bioprinting in cardiovascular medicine is currently limited by the lack of systematic demonstration of its effectiveness, high costs, and the complexity of the workflow. Here, we give a concise review of progress in cardiovascular bioprinting and its components. We further discuss the challenges and future prospects of cardiovascular bioprinting in clinical applications.

Original languageEnglish (US)
Pages (from-to)652-664
Number of pages13
JournalArtificial Organs
Issue number7
StatePublished - Jul 2021


  • 3D printing
  • bioprinting
  • cardiovascular
  • heart tissue
  • tissue engineering

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering


Dive into the research topics of 'Progress in cardiovascular bioprinting'. Together they form a unique fingerprint.

Cite this